Prospective registration of clinical trials published in the British Journal of Dermatology

British Journal of Dermatology

Volumn 171, Issue 4, 2014, Pages 681-683

  Batchelor, J ^a   Spuls, P I ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTHOR; DECISION MAKING; DERMATOLOGY; EDITORIAL; HEALTH CARE POLICY; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTRATION; PUBLICATION; REGISTER; STANDARDS; UNITED KINGDOM;

DERMATOLOGY; GREAT BRITAIN; PERIODICALS AS TOPIC; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES;

EID: 84919432991     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13314     Document Type: Editorial

References (17)

1. Anstey A,. The British Journal of Dermatology: 125 years, 28 editors, enduring values. Br J Dermatol 2013; 169: 238.
2. Williams H,. The outstanding record of clinical trials in the British Journal of Dermatology. Br J Dermatol 2014; 170: 761-3.
3. Saurat JH, Stingl G, Dubertret L, et al,. Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol 2008; 158: 558-66.
4. Ruzicka T, Lynde CW, Jemec GB, et al,. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158: 808-17.
5. Simes RJ,. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 1986; 4: 1529-41.
6. Dickersin K, Rennie D,. Registering clinical trials. JAMA 2003; 290: 516-23.
7. Dwan K, Gamble C, Williamson PR, et al,. Systematic review of the empirical evidence of study publication bias and outcome reporting bias-an updated review. PLoS ONE 2013; 8: e66844.
8. Nankervis H, Baibergenova A, Williams HC, Thomas KS,. Prospective registration and outcome-reporting bias in randomized controlled trials of eczema treatments: a systematic review. J Invest Dermatol 2012; 132: 2727-34.
9. Chalmers I, Glasziou P,. Avoidable waste in the production and reporting of research evidence. Lancet 2009; 374: 86-9.
10. Mathieu S, Boutron I, Moher D, et al,. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009; 302: 977-84.
11. Bourgeois FT, Murthy S, Mandl KD,. Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 2010; 153: 158-66.
12. AllTrials. Europe votes for clinical trial transparency. Available at: http://www.alltrials.net/2014/europe-votes-for-clinical-trial-transparency (last accessed 30 July 2014).
13. Goldacre B,. Improving, and auditing, access to clinical trial results. BMJ 2014; 448: g213.
14. Chan A-W,. Bias, spin, and misreporting: time for full access to trial protocols and results. PLoS Med 2008; 5: e230.
15. Ormerod AD, Williams HC,. Compulsory registration of trials. Br J Dermatol 2005; 152: 859-60.
16. Williams HC, Goldsmith L,. The JID opens its doors to high quality randomised controlled clinical trials. J Invest Dermatol 2006; 126: 1683-4.
17. Hoffman TC, Glasziou PP, Boutron I, et al,. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 2014; 348: g1687.